- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00272168
The Use of Skills Training to Augment Compensated Work Therapy (CWT)/VI for Veterans With SMI (MPROVE)
The Use of Skills Training to Augment CWT/VI for Veterans With SMI
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In spite of the fact that most individuals with serious mental illness (SMI) express a desire to work, some 80% of these individuals in the United States are chronically unemployed or under-employed. The VA has long recognized the need for vocational rehabilitation programs to facilitate meaningful work for patents with SMI. VA vocational rehabilitation programs (Compensated Work Therapy / Veterans Industries; CWT/VI) generally follow a supported employment model which has been the most extensively studied type of program and has garnered the most empirical support for helping individuals with SMI obtain employment. Nevertheless, studies of supported employment programs find that approximately 50% of participants remain unemployed and that job retention rates among those patients who do get jobs are quite low. In fact, more than half of all clients leave their supported employment positions within 6 months. The most frequently cited reasons for job terminations among patients with SMI include interpersonal problems in the work place and difficulty coping with symptom exacerbations.
The investigators have developed a psychosocial intervention (CBT-SST) that is designed to augment CWT/VI by targeting the skills needed for reintegration into community work settings and to facilitate job retention among persons with SMI. It is a manualized intervention that combines elements of cognitive-behavioral therapy (CBT) with work-related social skills training and basic problem solving training (SST). The CBT module of the treatment is designed to help reduce residual symptoms of mental illness and help patients develop strategies to cope with symptom exacerbations when they occur. The SST social skills and problem solving modules are designed to help patients improve their interpersonal functioning at work.
The purpose of this study is to conduct a randomized clinical trial comparing CWT/VI augmented with CBT-SST to CWT/VI without augmentation (control condition). The investigators will recruit patients for the study as they are beginning jobs through enrollment in the CWT/VI program at the VA, as this is the critical time period for them to develop the skills needed to perform well and retain employment. Expected outcomes for CBT-SST participants relative to controls include improved job retention and earnings, improved social skills (as assessed both in the clinic and in the actual work place), better everyday problem solving skills / social function, and improvements in quality of life.
The long term objective of this research is to develop and disseminate an effective skills training program that can improve work function and job retention among persons with SMI, and thereby enhance: a) their social role functioning; and b) their quality of life.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of schizophrenia or schizoaffective disorder, or other severe mental disorder including bipolar disorder, major depression, or severe anxiety disorder
- Enrolled in vocational rehabilitation program or working
- Age between 18 and 65 years
- Ability and willingness to attend treatment sessions for 3 months
- Judged by their treating clinician to be able to participate and provide informed consent
- Ability and willingness to provide informed consent to participate
Exclusion Criteria:
- Documented history of severe neurological disorder or head trauma with ongoing cognitive sequelae
- Inability to effectively participate in the baseline assessments due to intoxication or psychiatric symptoms on two successive appointments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm 1: MPROVE
The Maryland Program for Vocational Effectiveness (MPROVE)
|
psychosocial intervention that combines elements of cognitive-behavioral therapy (CBT) with work-related social skills training and basic problem solving training (SST)
Other Names:
|
Active Comparator: Arm 2: Control
Supportive Treatment for SMI (control)
|
Sessions are interactive, supportive, flexible, and unstructured, and are intended to help patients adjust to their new jobs and understand how working affects their lives.
The therapist stance is non-directive, and there is an emphasis on having patients share with one another, rather than having the therapists dictate the content of group sessions.
The primary goals of the therapists are to engage patients in treatment and to generate discussion among members.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Employment Status
Time Frame: Post Treatment (approximately 3 months after completion of the baseline assessment)
|
Data collected included from participants: 1) hours scheduled to work per week and 2) weekly wages earned.
|
Post Treatment (approximately 3 months after completion of the baseline assessment)
|
Work Performance (Work Behavior Inventory)
Time Frame: Post Treatment
|
This measure is completed with participants' supervisors and assesses current work behavior and vocational function. The WBI yields six scores related to fundamental work requirements: social skills, cooperativeness, work habits, work quality personal presentation, and a general score of overall work performance. Each of these is rated between 1-5:
The global impression of work behavior (overall rating of work functioning using the same 1-5 scale) was used for the purpose of reporting results for this study. |
Post Treatment
|
Social Functioning
Time Frame: Post Treatment
|
This was assessed using the Maryland Assessment of Social Competence (MASC), which assesses participants social problem solving skill abilities in both work-related and non-work related situations. Using three scenes, the participant is rated on the following scale for each scene. Overall score is then averaged to arrive at a final score.
|
Post Treatment
|
Employment Status
Time Frame: Post Treatment (approximately 3 months after completion of the baseline assessment)
|
Data collected included from participants: weekly wages earned
|
Post Treatment (approximately 3 months after completion of the baseline assessment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive Insight
Time Frame: Post Treatment
|
Cognitive insight was assessed using the Beck Cognitive Insight Scale, a 15-item questionnaire developed to evaluate patients' self-reflectiveness and their overconfidence in their interpretations of their experiences. Participant responses to each of these items were as follows:
Total score for the self-certainty scale could range from 6 to 24. Total score for the self-reflectiveness scale could range from 9 to 36. Total score for the composite score was calculated by subtracting the summed score for the self-certainty scale from the summed score of the self-reflectiveness scale and could range from 3 to 12, lower composite scores are an indicator of lower psychiatric functioning. |
Post Treatment
|
Psychiatric Symptoms
Time Frame: Post-Treatment
|
Psychiatric Symptoms were assessed using the Brief Psychiatric Rating Scale (BPRS), a widely used instrument for assessing the positive, negative, and affective symptoms of individuals who have mental illnesses.
The BPRS consists of 20 symptom constructs scored from 1 (not present) to 7 (extremely severe).
BPRS total score could range from 0 (not present) to 140 (extremely severe).
|
Post-Treatment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Wendy Tenhula, PhD, Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D3437-R
- H-26250 (Other Identifier: University of Maryland, Baltimore IRB number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Peking UniversityNot yet recruitingTreatment-resistant Schizophrenia
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
-
NYU Langone HealthNot yet recruitingTreatment-resistant SchizophreniaUnited States
Clinical Trials on Maryland Program for Vocational Effectiveness
-
Brain Injury Center BOMI, Roskilde, DenmarkRigshospitalet, Denmark; University of Copenhagen; Hospital de CrucesUnknown
-
Tuscaloosa Research & Education Advancement CorporationUnited States Department of DefenseUnknown
-
Hacettepe UniversityBiruni UniversityCompleted
-
VA Office of Research and DevelopmentCompletedMental IllnessUnited States
-
University of Alabama at BirminghamNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedArthritis | Musculoskeletal Diseases | Rheumatic DiseasesUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
John T. NosekCompletedIntellectual Disability | Autism Spectrum DisorderUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Medical SystemWithdrawnHeart Failure | Pneumonia | Hypertension | Pulmonary Disease, Chronic Obstructive | Patient Readmission | Diabetes Mellitus Poor ControlUnited States
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Schizoaffective Disorder | Bipolar Disorder | Major Depression | Chronic Mental DisorderUnited States
-
Gazi UniversityNot yet recruitingCaregivers With a Child Followed up With a Cancer DiagnosisTurkey